findmyKOL

Sharon Fekrat, MD

Basic profile

Robert Machemer, MD, Distinguished Professor of Ophthalmology · Duke University

ORCID↗NPI↗
✓ Full record
Region🇺🇸 Wilson, NC · Southeast · United StatesSpecialtyOphthalmologyFocusRetinal Diseases and Treatments+4
Active KOLfindmyKOL type: EliteLatest publicationSee ScholarshipOnline presenceverified 2026Payments2021 onwardNIH fundingNot yet indexedWhy? →

Sharon Fekrat is Robert Machemer, MD, Distinguished Professor of Ophthalmology at Duke University. OpenAlex indexes 329 publications with 5,387 citations (h-index 36); ClinicalTrials.gov lists 2 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Ophthalmology profiles in the findmyKOL directory.

Overview

Updated 19 Oct 2026

Sharon Fekrat, MD, is Robert Machemer, MD, Distinguished Professor of Ophthalmology at Duke University. The public record shows 329 publications with 5,408 citations (h-index 36), centered on Retinal Diseases and Treatments, Retinal and Macular Surgery, Ocular Diseases and Behçet’s Syndrome. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 24 companies.

  • Most recent indexed publication: 2026 · Journal of vitreoretinal diseases
  • Top research focus: Retinal Diseases and Treatments
  • 3 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 24 companies

Generated from the cited public record · current as of 19 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Macular Degeneration (AMD)2 trialsAlzheimer's / Dementia1 trialGeographic Atrophy1 trialParkinson's Disease1 trialMultiple Sclerosis1 trialALS1 trialCognitive Dysfunction1 trialDementia1 trialWounds and Injuries1 trialBrain Injuries, Traumatic1 trialDown Syndrome1 trialHuntington Disease1 trialLewy Body Disease1 trialFrontotemporal Dementia1 trialMotor Neuron Disease1 trial

Research focus

OpenAlex concept fingerprint
Retinal Diseases and TreatmentsRetinal and Macular SurgeryOcular Diseases and Behçet’s SyndromeRetinal Imaging and AnalysisDementia and Cognitive Impairment Research

Drugs & molecules

across trials, industry payments and publications
Xiperegeneric · TriamcinoloneClinical trials—Industry payments11Publications1EYLEA HDClinical trials—Industry payments25Publications—Vabysmogeneric · FaricimabClinical trials—Industry payments16Publications—Iluviengeneric · FluocinoloneClinical trials—Industry payments13Publications—Ozurdexgeneric · DexamethasoneClinical trials—Industry payments13Publications—Syfovregeneric · PegcetacoplanClinical trials—Industry payments10Publications—Susvimogeneric · RanibizumabClinical trials—Industry payments9Publications—Eyleageneric · AfliberceptClinical trials—Industry payments5Publications—CorticotropinClinical trials—Industry payments2Publications—Iheezogeneric · ChloroprocaineClinical trials—Industry payments2Publications—Izervaygeneric · Avacincaptad pegolClinical trials—Industry payments2Publications—Brilliant blue GClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Bausch & Lomb Americas Inc.Clinical trials—Industry payments26Regeneron Pharmaceuticals, Inc.Clinical trials—Industry payments23Apellis Pharmaceuticals, Inc.Clinical trials—Industry payments20Alcon Vision LLCClinical trials—Industry payments14Genentech USA, Inc.Clinical trials—Industry payments12Glaukos CorporationClinical trials—Industry payments9ANI Pharmaceuticals, Inc.Clinical trials—Industry payments8Genentech, Inc.Clinical trials—Industry payments8Harrow Eye, LLCClinical trials—Industry payments8Abbvie Inc.Clinical trials—Industry payments6Regeneron Healthcare Solutions, Inc.Clinical trials—Industry payments6EyePoint Pharmaceuticals US, Inc.Clinical trials—Industry payments5Ocular Therapeutix, Inc.Clinical trials—Industry payments5Alimera Sciences, Inc.Clinical trials—Industry payments4Coherus Biosciences Inc.Clinical trials—Industry payments3Duke UniversityClinical trials3Industry payments—Astellas Pharma US IncClinical trials—Industry payments2Neurotech Pharmaceuticals, Inc.Clinical trials—Industry payments2Alcon Research LLCClinical trials—Industry payments1Biogen, Inc.Clinical trials—Industry payments1Cardinal Health 110 LLCClinical trials—Industry payments1Dutch Ophthalmic, USAClinical trials—Industry payments1Heidelberg Engineering, Inc.Clinical trials—Industry payments1Lupin Inc.Clinical trials—Industry payments1Topcon Healthcare, Inc.Clinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
329publications

Distinct works indexed by OpenAlex, matched via ORCID.

5,387citations

Total citations across indexed works.

36h-index

Hirsch index (OpenAlex). i10-index 101.

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials ↓
24companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Public positions

sourced statements on record
  • Fellow

    American College of Surgeons (FACS)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asrs.org ↗
  • Fellow

    American Society of Retina Specialists (FASRS)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asrs.org ↗
  • Board-certified vitreoretinal surgeon
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asrs.org ↗

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1707 Medical Park Dr W
Wilson, NC 27893-2788

Telephone

252-291-7008

Registry record last updated 3 Oct 2014 · collected 28 Jul 2026.

View the NPPES registry record

Clinical trials

Updated 19 Oct 2026

Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 19 Oct 2026

24 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

All 50 payment records: search, sort and filter.Explore →
View the CMS Open Payments record ↗

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    59.5%
    Corticosteroid34.8%
    Prednisolone Acetate100%
    Part D≥31 patients
    Prostaglandin Analog9.5%
    Latanoprost100%
    Part D<11 patients

    + 2 more classes in this area

  • Musculoskeletal

    40.5%
    Cyclooxygenase Inhibitor40.5%
    Ketorolac Tromethamine100%
    Part D≥25 patients
Where care is delivered (Part B)22.1% facility · 77.9% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Updated 19 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

All 5 publications: search, sort and filter.Explore →

Most-cited works

by citation count (OpenAlex)
  1. 01
    NATURAL HISTORY OF SUBFOVEAL SUBRETINAL HEMORRHAGE IN AGERELATED MACULAR DEGENERATION
    Article334 citations1996
    doi.org ↗
  2. 02
    Pars plana vitrectomy, subretinal injection of tissue plasminogen activator, and fluid–gas exchange for displacement of thick submacular hemorrhage in age-related macular degeneration
    Article233 citations2001
    doi.org ↗
  3. 03
    Retinal Microvascular and Neurodegenerative Changes in Alzheimer’s Disease and Mild Cognitive Impairment Compared with Control Participants
    Article228 citations2019
    doi.org ↗
  4. 04
    Subretinal Hyperreflective Material in the Comparison of Age-Related Macular Degeneration Treatments Trials
    Article221 citations2015
    doi.org ↗
  5. 05
    Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion
    Article219 citations2003
    doi.org ↗
All 329 cited works: search, sort and filter.Explore →

Network

Updated 19 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Dilraj Singh Grewal98Cason B. Robbins76Sandra S. Stinnett66Akshay S. Thomas35Justin P. Ma27Rupesh V. Agrawal24Kim G. Johnson22Stephen P. Yoon22Atalie C. Thompson21Srinath Soundararajan20Anita Kundu19Alice Haystead18Clayton Ellis Wisely17Henry L. Feng17Bryce W. Polascik17Suzanna Joseph16Prithvi Mruthyunjaya15Glenn J. Jaffe15Andy Liu15Ariana Allen14Srilaxmi Bearelly12Terry Lee12Burton L. Scott11Richmond Woodward11Paul Hahn11Angela Hemesath11Allen C. Ho10Francis Char DeCroos10Carl D. Regillo10Sunir J. Garg9Julia A. Haller9Sunil K. Srivastava9Justis P. Ehlers9Tom MacGillivray9Peter J. Weng9Duncan E. Berry8Delaram Mirzania8Ricardo Henao8James H. Powers8Cynthia Ann Toth8

Online presence

Updated 19 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/sharon-fekrat-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • LinkedIn

    linkedin.com/in/sharon-fekrat-md-facs-315a31a6

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
  • Other

    scholars.duke.edu/person/fekra001

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholars.duke.edu ↗
  • Other

    asrs.org/find-a-specialist/profile/615/Sharon-Fekrat

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asrs.org ↗
  • Other

    dukehealth.org/find-doctors-physicians/sharon-fekrat-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dukehealth.org ↗

Mentions by others

where others cite or feature them
  • Apple Podcasts

    aao.org/audio/episode-196-dr-sharon-fekrat-on-alpha-melanocyte-s

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aao.org ↗
  • Other

    eyesoneyecare.com/authors/sharon-fekrat-md-facs-fasrs

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →eyesoneyecare.com ↗
  • Other

    multimedia.asrs.org/media/episode-196-dr-sharon-fekrat-on-vitreretinal-fello-5132

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →multimedia.asrs.org ↗
  • Other

    ophthalmologytimes.com/authors/sharon-fekrat-md-fasrs

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ophthalmologytimes.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 19 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • Vice Chair

    Faculty Affairs, Department of Ophthalmology, Duke University

    2024
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholars.duke.edu ↗
  • Professor

    Department of Neurology, Duke University

    2021
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholars.duke.edu ↗
  • Associate Professor

    Department of Surgery, Duke University

    2015
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholars.duke.edu ↗
  • Associate Chief of Staff of Microsurgery and Specialty Services

    Durham VA Medical Center

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asrs.org ↗
  • Director

    Vitreoretinal Surgery Fellowship, Duke Eye Center

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asrs.org ↗
  • Vice Chair of Faculty Affairs

    Department of Ophthalmology, Duke University

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholars.duke.edu ↗

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”